Keyword: Merck

News

Sanofi to Buy Hemophilia Specialist Bioverativ

24.01.2018 - Sanofi is boosting its presence in blood disorders through the acquisition of Bioverativ, the former hemophilia business of major US biotech Biogen, which was spun out in February...

News

UK Watchdog Finds Concordia Guilty of Market Abuse

30.11.2017 - In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...

News

Pfizer Mulls Sale of Consumer Health Unit

13.10.2017 - Pfizer is reviewing the future of its Consumer Healthcare division. The US drug major said it is considering a range of options, including a full or partial separation through a...

News

Teva Sheds Assets Worth $2.48 Billion

22.09.2017 - Israeli generics giant Teva has completed its exit from the women’s health sector. On Sept. 18 it unloaded its contraception, fertility, menopause and osteoporosis products to CVC...

News

Old Levothyrox to be Reintroduced in France

18.09.2017 - An older version of a thyroid drug made by Merck Serono is planned to be reintroduced in France after more than 9,000 of the country's three million users complained of serious...

News

Merck KGaA May Sell Consumer Health

07.09.2017 - Germany’s Merck KGaA is weighing options for its Consumer Health business, which it says has a strong market position but needs more investment to grow sufficiently. The chemicals...

News

EU Approves Merck KGaA MS Tablets for Marketing

29.08.2017 - The European Commission has granted marketing authorization for Merck KGaA’s Cladribine tablets for treatment of highly active relapsing multiple sclerosis (RMS) in the EU 28, in...

News

Merck KGaA Opens Applications Lab in Shanghai

01.08.2017 - German pharmaceuticals, chemicals and life sciences group Merck has opened a new application laboratory for its Performance Materials business sector in Shanghai, China. The...